about
Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposureAnorgasmia with gabapentin may be common in older patients.Writing from the wards: advice for residents.Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein.Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line.Clinical Reasoning: a 54-year-old man with unilateral weakness and vascular risk factorsInteraction of triazolam and ketoconazole in P-glycoprotein-deficient mice.Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.Iatrogenic hyperammonemia after anorexia.Methadone inhibits rhodamine123 transport in Caco-2 cells.P-glycoprotein interactions of nefazodone and trazodone in cell culture.Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells.Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir.Differential metabolism of midazolam in mouse liver and intestine microsomes: a comparison of cytochrome P450 activity and expression.Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.Reduced levels of substance P in the brains of Cpe(fat)/Cpe(fat) mice.Gabapentin use in the prevention of succinylcholine-induced fasciculation and myalgia.Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.Constructional Apraxia Reversed With MethylprednisoloneTeaching Video NeuroImages: The elusive L5 reflexIdentification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK gly content and secretion from endocrine tumor cells by an inhibitor of amidation
P50
Q28366014-4277B6B0-158B-49D1-98A3-CF2357490AEBQ33907921-1B8D525F-F2D1-49EB-85B9-E869DF2E8648Q34172880-480E0DB9-4B8C-4222-BB2F-154A754E0CA8Q40685094-A2A16112-1E28-45BA-B5DA-52BBAB7B94C0Q40763015-34FC228B-6B67-4DDA-BEC6-39A03EE05080Q41904491-92E376F1-97C1-46CD-8B9B-887EC979CB11Q42464794-18FB39DE-E98E-4BAF-A620-7EEF769D937FQ42468095-826503C4-8F00-4AB6-87D3-0A54566C0FBCQ43138143-B169CBED-1282-4E14-B99C-E42EE7BCCD98Q43641630-7DB350F4-D2C1-4807-826A-3CD6AFA13042Q43673448-50CE9390-AD3B-4E67-94B9-295483C0852CQ43930852-ADEA3908-DD68-47C1-8C8E-87B857F90C00Q44103376-E64DA472-106F-454E-B5F2-D48C65E58552Q44106452-5D3F5A27-2118-4309-83D7-324B7EDE5978Q44202487-EA227C9B-FDD9-40A1-8E93-DAA122BE37DBQ44440238-D7177913-FFDB-4DEB-A5D6-F2EF3BE03C1FQ44777237-AB03E77F-97DE-44C4-81F0-DCAF1D22C350Q47698786-C3F402C4-C325-4596-8D53-5F684A172D87Q50152716-4434587D-F26E-4FA0-837E-C21943F66E71Q51461352-9246C151-3943-484A-96EC-F0ABAEC2E901Q52580698-AD2842F8-5DE4-40B7-A230-9AB0A612B9B0Q57393402-76713772-9230-4951-A6C8-8F1774EE7225Q61637262-CAD159E0-AF83-4595-8506-90236C1B7538Q61637279-DC008AE7-8AEC-458A-B3AE-2F9720811B09
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael D Perloff
@ast
Michael D Perloff
@en
Michael D Perloff
@es
Michael D Perloff
@nl
Michael D Perloff
@sl
type
label
Michael D Perloff
@ast
Michael D Perloff
@en
Michael D Perloff
@es
Michael D Perloff
@nl
Michael D Perloff
@sl
prefLabel
Michael D Perloff
@ast
Michael D Perloff
@en
Michael D Perloff
@es
Michael D Perloff
@nl
Michael D Perloff
@sl
P106
P21
P31
P496
0000-0002-0027-9780